Masimo (MASI)

• Market cap: $9.16B
• 1 day: 1.38%
• 5 days: 4.66%
• 1 month: -1.02%
• 3 months: 20.52%
• 6 months: 58.11%
• Year to date: 2.21%
• 1 year: 40.56%
• 5 years: 1.50%
• 10 years: 546.73%
• Sector: Healthcare
• Industry: Electromedical & Electrotherapeutic Apparatus

About: Masimo Corp is a global technology company. The company's segment includes healthcare and non-healthcare. The healthcare business segment is a key revenue driver, develops, manufactures, and markets a variety of noninvasive patient monitoring technologies, hospital automation and connectivity solutions, remote monitoring devices and consumer health products. Its non-healthcare segment includes consumer audio business develops, manufactures, markets sells and licenses premium and luxury audio sound products and related integration technologies.

Employees: 3,796

Fund manager confidence

Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)

173% more call options, than puts

Call options by funds: $117M | Put options by funds: $43M

22% more first-time investments, than exits

New positions opened: 61 | Existing positions closed: 50

6% more capital invested

Capital invested by funds: $6.31B [Q2] → $6.7B (+$390M) [Q3]

2% more funds holding

Funds holding: 347 [Q2] → 354 (+7) [Q3]

0.35% more ownership

Funds ownership: 94.25% [Q2] → 94.61% (+0.35%) [Q3]

0% more funds holding in top 10

Funds holding in top 10: 3 [Q2] → 3 (+0) [Q3]

12% less repeat investments, than reductions

Existing positions increased: 106 | Existing positions reduced: 121

Research analyst outlook

4 Wall Street Analysts provided 1 year price targets over the past 3 months

• Low target: $190 10% upside
• Avg. target: $197 14% upside
• High target: $210 22% upside

4 analyst ratings

• positive: 4 100%
• neutral: 0 0%
• negative: 0 0%

Raymond James Jayson Bedford 63% 1-year accuracy 15 / 24 met price target	13% upside $194	Outperform Maintained	27 Dec 2024
Piper Sandler Jason Bednar 37% 1-year accuracy 13 / 35 met price target	22% upside $210	Overweight Maintained	18 Dec 2024
Wells Fargo Vik Chopra 70% 1-year accuracy 7 / 10 met price target	12% upside $193	Overweight Maintained	11 Dec 2024
Stifel Rick Wise 72% 1-year accuracy 21 / 29 met price target	10% upside $190	Buy Reiterated	22 Nov 2024